Admix Pharma Analytical Laboratories is Your Solution to Rapidly Increasing Requirements in Cannabinoids Products, We are Here for You!
Admix Pharmaceutical Laboratory is a state-of-the-art modern full cGMP facility registered and inspected with FDA, DEA (Schedules I through V and List I Chemicals), and EPA. Our knowledgeable technical staff will be able to resolve any of your technical challenges and suggest the best solution. We are conveniently located in South Plainfield, NJ only 30 minutes away from New York City.
For the last 20 years we have been performing Analytical Testing and Product Development of Intermediates and Finished Products for Pharmaceutical (including Cannabinoids products) and Nutraceutical companies with our array of Product Development and Analytical Testing Laboratory Equipment. We have expertise in testing and development of Liquid, Suspension and Solid Dose products.
In the last few years our company focus is Analytical Services and Generics ANDA development.
Our analytical laboratory is equipped to perform all necessary Analytical Testing and Develop product containing different type of Cannabinols in different dosage forms.
This Analytical testing includes:
Raw Material Testing for:
Impurities Level (see table below)
Pesticides Trace Amounts
Finished Product for Potency and Impurities Level
Extended Compounds Testing May Include Compounds Listed in Table Below
Definition - Cannabigerol is the non-acidic form of cannabigerolic acid, the parent molecule from which other cannabinoids are synthesized. Cannabigerol is a minor constituent of cannabis.
Therapeutic Effects- CBGA functions kind of like a stem cell in the cannabis plant. CBGA produces effects on anti-proliferative (anti-cancer), anti-bacterial, anti-inflammatory, and analgesic attributes. CBGA the most important of all of cannabis’ chemical compounds, especially given the centrality THC and CBD have taken in today’s discussion of cannabis’ place in our medicine. So here is a refresher on the cannabinoids CBGA is responsible for synthesizing, including two that are not nearly as researched as THC and CBD.
Definition - THC is the primary chemical responsible for most of the psychoactive effects associated with cannabis. The effects of THC are induced rapidly as the chemical binds to endocannabinoid receptors in the brain, central nervous system and the immune system.
Therapeutic Effects - THC produces effects on mood, memory, motor coordination, cognitive ability, sensorium, time sense, and self-perception. THC also has the potential to reduce the effects of inflammation created diseases, like rheumatoid arthritis, because it blocks the production of inflammation-producing hormones.
Definition - CBDa is the acidic precursor to CBD. CBDa is found in either live or raw forms of cannabis, but it isn't until the plant is dried, cut and heated that CBD is created.
Therapeutic Effects - CBDa works in the EVS as an inhibitor to the COZ-2 enzyme, which gives it the ability to reduce inflammatory activity in the body. Therepeutic benefits include; reducing inflamation, treating nausea and vomiting, helping with psychosis, and helps promote sleep.
Definition - CBC-a is non-psychoactive, unlike THC, and is located in the most abundant levels in tropical marijuana plant strains.
Therapeutic Effects - CBC acts on CB1 and CB2 receptors in our nervous system. Therapeutic benefits include; anti-inflammatory, anti-depressant, reduce pain caused by nerve damage, analgesic, neuroprotector, anti-bacterial and anti-fungal, reduces acne, gastrointestinal and inflammatory disorders possessing anti-diarrheal properties, inhibits absorption of anandamide which has been linked to reduction of various types of cancer, and the reduction of migranes.
Definition - CBGVA is a precursor cannabinoid which undergoes its own series of enzymatic reactions to form a new 'family' of cannabinoids. These molecular transformations take place in response to changes in environment or weather. As the cannabis plant ages, the initial CBGVA in the plant will react to form the new cannabinoids. Since CBGVA is also one of the produced acids of CBD thus we can say that it might possess similar benefits as that of CBG.
Therapeutic Effects - CBG has long lasting effects in reducing inflammation to inflammatory bowel disease, Anti-cancer, it can be concluded that CBGVA might also possess similar medicinal benefits.
Definition - THCV doesn't begin as cannabigerolic acid unlike THC, CBD, and CBC. CBGVA is broken down to tetrahydrocannabivarin carboxylic acid (THCVA) by the enzyme THCV synthase. At that point, THCVA can be decarboxylated to create THCV.
Therapeutic Effects - A new potential treatment against obesity-associated glucose intolerance.
Definition - CBCV
Therapeutic Effects - CBCVA targets receptors in the body to help with daily functions such as appetite, sleep patterns, mood, and movement.
Definition - CBCV is a propyl cannabinoid, which differentiates from CBC, CBCV's predecessor and counterpart. Since CBCV is a propyl cannabinoid, this simply means that the molecular structure is different than its predecessor.
Therapeutic Effects - CBCV is known specifically to be an extremely effective anticonvulsant.